2019 News Articles

TMIST PI Pisano: “Are we further reducing breast cancer mortality the more intensively we screen?”

Portrait of Etta Pisano, MD Posted 03/19/2019
The Tomosynthesis Mammographic Imaging Screening Trial, a massive randomized trial of early detection, is asking an important question:  Is digital breast tomosynthesis better than digital mammography in reducing development of advanced breast cancer? “We’ve done a really good job of getting women in to get screened, and that’s good because we are undoubtedly saving lives through screening,” Etta Pisano, the PI of the study led by ECOG-ACRIN Cancer Research Group, said to The Cancer Letter. “The question is, are we further reducing breast cancer mortality the more intensively we screen?”
All | 2019 | 2018 | 2017 | 2016

PREVENT and Consortia Project Results to be Presented at the AACR Annual Meeting 2019

NCI is participating in the American Association for Cancer Research (AACR) Annual Meeting held March 29 - April 3, 2019 at Georgia World Congress Center in Atlanta, GA, including presenting the following research results... Read More

POSTED: 03/15/2019

NCORP Tissue Procurement Protocol to Open at 12 Community Sites

At 12 NCI Community Oncology Research Program (NCORP) sites across the United States, a new kind of study will soon be opening for patients with advanced malignancies being treated with molecularly targeted therapies. The... Read More

POSTED: 03/01/2019
Image of a DNA double helix

After Lung Cancer Screening, Follow-Up Procedures May Be Riskier than Thought

Being screened for lung cancer can lead to follow-up diagnostic procedures, including invasive ones. The risk of complications from those invasive procedures may be higher than previously thought, a new study suggests. By... Read More

POSTED: 02/08/2019
A person being screened for lung cancer with a low-dose CT scan.

Newest NCORP Affiliate in Guam Brings Access to Cancer Clinical Trials

FHP Health Center in Guam was approved in January as the newest affiliate of the National Cancer Institute Community Oncology Research Program (NCORP) to bring cancer clinical trials and cancer care delivery studies to... Read More

POSTED: 01/24/2019
University of Hawaii Cancer Center Minority/Underserved NCORP team visiting FHP Health Center-Guam

Nutrition Frontiers - Winter 2019

Volume 10, Issue 1 Dear Nutrition Enthusiast, The winter issue of Nutrition Frontiers celebrates the beginning of 2019 and showcases the potential beneficial effects of a dietary pattern of whole grains, legumes, fruits... Read More

POSTED: 01/24/2019
Image of foods high in whole grains, legumes, and fruits and vegetables.

The Final Verdict on Finasteride

Finasteride, a generic hormone-blocking drug, was found to reduce the risk of prostate cancer by 25 percent in the landmark Prostate Cancer Prevention Trial (PCPT). Long- term data, published today in the New England Journal... Read More

POSTED: 01/23/2019

Managing Cancer Pain: Are Better Approaches on the Horizon?

Pain is a common and much-feared symptom among people being treated for cancer and long-term survivors. Cancer pain can be caused by the disease itself, its treatments, or a combination of the two. It may be short-lived or... Read More

POSTED: 01/23/2019
Sensory nerve fibers (red) sprouting into prostate tumor cells (green) that have metastasized to the bone. Credit: Patrick Mantyh, PhD, JD, University of Arizona

Hepatitis Goes Undiagnosed in Cancer Patients

Results from the largest study of hepatitis B and C and HIV infection prevalence in cancer patients show that an alarmingly high rate of undiagnosed acute and chronic hepatitis B and C. Hepatitis B and C are serious but... Read More

POSTED: 01/17/2019
Portrait of Scott Ramsey, MD, PhD

For Early-Stage Lung Cancer, Study Identifies Potential New Biomarker, Treatment Target

A new study has identified a potential biomarker of early-stage non–small cell lung cancer (NSCLC). The biomarker could help diagnose precancerous lung growths (called nodules or lesions) and early-stage lung cancers... Read More

POSTED: 01/03/2019
Imaging scans identified a lung nodule (panels A and B) which, over the course of 11 months progressed (panels C and D) and, following a biopsy, was confirmed as lung cancer.